[
  {
    "ts": null,
    "headline": "DGX Q1 Earnings Call: Acquisitions, Advanced Diagnostics, and Operational Initiatives Drive Growth",
    "summary": "Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 12.1% year on year to $2.65 billion. The company expects the full year’s revenue to be around $10.78 billion, close to analysts’ estimates. Its non-GAAP profit of $2.21 per share was 2.9% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=eae2cfcda764b49764c855a74c486cb43c9441cdf489cabb72984c74e692b7dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746980619,
      "headline": "DGX Q1 Earnings Call: Acquisitions, Advanced Diagnostics, and Operational Initiatives Drive Growth",
      "id": 134379809,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 12.1% year on year to $2.65 billion. The company expects the full year’s revenue to be around $10.78 billion, close to analysts’ estimates. Its non-GAAP profit of $2.21 per share was 2.9% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=eae2cfcda764b49764c855a74c486cb43c9441cdf489cabb72984c74e692b7dd"
    }
  }
]